探索临床药师参与分化型甲状腺癌的术后管理方式.选取我院甲状腺乳腺外科行甲状腺切除术的分化型甲状腺癌患者107例,随机分为实验组和对照组,其中实验组55人,对照组52人.临床药师应用慢病管理系统对实验组进行管理;对照组仅接受常规的药学服务.随访1年后,实验组患者甲状腺功能达标情况、达标时间、依从性与对照组均有显著的统计学差异,但两组患者药物不良反应发生情况并无显著性差异.临床药师应用慢病管理系统为实验组患者制定个体化随访方案和药学监护,显著缩短了术后甲状腺功能达标时间,提高了达标率和依从性.%A total of 107 differentiated thyroid cancer (DTC) patients were randomly divided into experimental group and control group. The clinical pharmacists applied the chronic disease management system to follow up the experimental group. The control group only received conventional pharmaceutical services. After one year of follow-up, the results of thyroid function compliance rate, compliance time and patient compliance of the experimental group were significantly better than those of the control group. There was no significant difference of the incidence of side effects between the two groups. Clinical pharmacists managing patients through chronic disease management system provided a new management approach for DTC patients. Individualized follow-up programs for patients significantly shortened compliance time and improved compliance rate and patient compliance.
展开▼
